Erirab 20mg Tablet contains Rabeprazole, a proton pump inhibitor (PPI) used primarily to reduce gastric acid secretion. It is indicated for the treatment of gastroesophageal reflux disease (GERD), erosive esophagitis, Zollinger-Ellison syndrome, and peptic ulcer disease. Rabeprazole acts by selectively inhibiting the H+/K+ ATPase enzyme system at the secretory surface of gastric parietal cells, thereby suppressing the final step in acid production. This results in decreased gastric acidity, promoting ulcer healing and symptom relief. Erirab 20mg is typically administered orally once daily, preferably before meals, and the dosage may be adjusted based on clinical response and specific indications. It is generally well tolerated; however, potential side effects include headache, diarrhea, nausea, abdominal pain, and dizziness. Long-term use may be associated with risks such as vitamin B12 deficiency, hypomagnesemia, and increased susceptibility to gastrointestinal infections. Caution is advised in patients with liver impairment, and drug interactions should be considered, particularly with medications metabolized via the cytochrome P450 system. Erirab 20mg should be used under medical supervision, with adherence to prescribed dosage and duration to ensure optimal therapeutic outcomes and minimize adverse effects.